Business Wire

2020 Yiwu Imported Commodities Fair is Being Held in World Capital of Small Commodities

13.11.2020 16:38:00 EET | Business Wire | Press release

Share

The 2020 China Yiwu Imported Commodities Fair opened in Yiwu City on November 13, 2020 and will continue until the 16th. As a professional, international and market-oriented event, Yiwu Imported Commodities Fair is committed to becoming China's top brand for imported consumer goods.

View the 2020 Yiwu Imported Commodities Fair album:

https://as.alltuu.com/v4/albumset/1001142273/

The Fair has five pavilions, namely Quality Life (Wine & Coffee), Asia Pavilion, Europe Pavilion, America-Oceania-Africa Pavilion, and Quality Life (Home Decoration Materials), to exhibit products from 78 countries and regions.

The Fair attracted nearly 1,000 exhibitors, one third of which were newcomers. Among them were the second largest butter cookie manufacturer from Denmark, the well-known organic superfood manufacturer from Germany, and many well-known Australian companies. Meanwhile, as this year’s Fair was opened right after the closure of China International Import Expo (CIIE) in Shanghai, 93 CIIE exhibitors also came to the Fair, a significant increase from last year’s 26.

Government participants included the Consulate General of the Republic of Korea in Shanghai, the Consulate General of the Socialist Republic of Vietnam in Shanghai, the Consulate General of the Eastern Republic of Uruguay in Shanghai, the China-Britain Business Council, The Canada International Trade Promotion Society, and the West Australia Trade and Investment Promotion Council.

As the country of honor, Russia brought more than 30 companies including the Russian Agricultural Group. Representatives from the Russian Consulate in Shanghai, the Russian Cultural Center in Beijing, and the Russian Export Center Group attended the Fair to showcase various aspects of the country, including economy, trade, culture and arts.

Varied supporting activities were prepared for exhibitors, buyers and visitors. In addition to a number of business themed forums and business matchmaking meetings, multiple cultural activities were held. For instance, Russia brought ethnic performances and food appreciation; the British Pavilion invited visitors on site to experience the purest British fashion; the Latte Art competition in the coffee products area attracted a lot of attention.

Another highlight of the Fair was the debut of the mascot “Jin Jin”, a lively and lovely white gosling, whose vibrant cartoon image reflects the enthusiasm and diversity of the Fair, greatly enhancing the image awareness of the Fair.

For more:

Official website: http://www.importfair.cn/en

Facebook: https://www.facebook.com/yiwuimportfair/

Instagram: https://www.instagram.com/yiwu_importedfair/

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Chim Chen
service@yiwufair.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist19.6.2026 10:00:00 EEST | Press release

IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointments of Dr. Craig Ciesla as Chief Technology Officer (CTO) and Dr. Inés de Vega as Chief Scientist, as she transitions from her role as Vice President of Quantum Solutions, deepening IQM´s leadership as the company prepares for its planned Nasdaq listing through a merger with Real Asset Acquisition Corp. (Nasdaq: RAAQ). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260619693929/en/ From left to right: Dr. Inés de Vega, Chief Scientist, and Dr. Craig Ciesla, Chief Technology Officer. Ciesla, an experienced deep tech executive with more than 25 years delivering products across multiple industries from startups to Fortune 500 companies, will advance IQM's technology strategy and drive its implementation into systems and products. De Vega, meanwhile, will be responsible for ensuring scientific feasibility and system-level

Teijin Receives Approval for Additional Indications of XEOMIN ® for Cervical Dystonia and Blepharospasm in Japan19.6.2026 10:00:00 EEST | Press release

Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, and Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, jointly announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the additional indications for XEOMIN® (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm. This approval represents the fourth and fifth indications for XEOMIN® authorized in Japan, alongside its existing approvals for the treatment of upper limb spasticity, lower limb spasticity and chronic sialorrhea. Cervical dystonia is a focal dystonia characterized by involuntary contractions of the neck muscles, resulting in abnormal or repetitive movements and postures.1 Blepharospasm is also a focal dystonia, characterized by excessive involuntary contractions of the muscles surrounding the eye.2 Both conditions significantly impact patients’ quality of life. The approval by MHLW is based on Phase III clinic

Incyte Japan Announces Approval of Minjuvi ® (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)19.6.2026 09:00:00 EEST | Press release

Incyte Biosciences Japan G.K. today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Minjuvi® (tafasitamab) in combination with lenalidomide for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). “This approval provides a new option for patients in Japan living with relapsed or refractory DLBCL, an aggressive disease with historically limited treatment options,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “We are committed to helping address critical unmet needs for patients and their families affected by this challenging cancer.” DLBCL is the most common subtype of non-Hodgkin lymphoma and is an aggressive malignancy of B lymphocytes. While many patients respond to initial therapy, outcomes remain poor for those with relapsed or refractory disease, particularly for patients who are not eligible for autologous stem cell transplant.1 The approval is based on results from the MOR208C203 Trial: L

Amazfit Introduces Helio Strap Pro, Bringing Body-Worn Movement Intelligence to HYROX and Hybrid Training18.6.2026 20:07:00 EEST | Press release

Amazfit, a leading global smart wearable brand owned by Zepp Health (NYSE: ZEPP), today announced Helio Strap Pro, a body-worn training system designed to help HYROX and hybrid athletes better understand how their bodies perform under load. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260618031434/en/ Amazfit Introduces Helio Strap Pro, Bringing Body-Worn Movement Intelligence to HYROX and Hybrid Training Building on the screen-free Helio Strap, Helio Strap Pro adds a dedicated waist-mounted motion sensor that captures core-body movement and stability during training. Combined with upper-arm heart-rate sensing and compatible Amazfit smartwatches, the system provides a more complete picture of cardio effort, movement quality and muscle load than wrist-based tracking alone. Helio Strap Pro represents the next evolution of Amazfit's Hybrid Training System, extending performance tracking beyond heart rate to help athletes bett

HyperLight Announces $80 Million Series C to Accelerate TFLN Deployment for AI Infrastructure18.6.2026 18:30:00 EEST | Press release

HyperLight Corporation (“HyperLight”), a leader in thin-film lithium niobate (TFLN) photonics, today announced the closing of an $80 million Series C financing round led by MediaTek. The round includes participation from UMC Capital, Jabil, Foxconn, EDBI (arm of SG Growth Capital, the investment platform of the Singapore Economic Development Board and Enterprise Singapore), CDIB-TEN Capital, and Qatar Investment Authority (QIA), as well as strategic investors from leading silicon IC and networking companies. Existing investors Summit Partners, The Engine, Foothill Ventures, and Xora Innovation continue to actively support the company’s growth. The financing brings together companies across the AI infrastructure value chain — including silicon ICs, foundry manufacturing, electronics manufacturing services, networking, and global infrastructure investment — reflecting broad ecosystem support for scaling TFLN photonics into production. “This financing is about more than capital — it is ab

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye